State of Wisconsin Investment Board
BBIO icon

State of Wisconsin Investment Board’s BridgeBio Pharma BBIO Stock Holding History

State of Wisconsin Investment Board’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.57M Sell
88,181
-1,895
-2% -$133K 0.01% 906
2026
Q1 		$6.69M Sell
90,076
-1,327
-1% -$96.2K 0.02% 867
2025
Q4 		$6.99M Buy
91,403
+151
+0.2% +$9.91K 0.02% 858
2025
Q3 		$4.74M Buy
91,252
+19,601
+27% +$956K 0.01% 988
2025
Q2 		$3.09M Sell
71,651
-5,048
-7% -$184K 0.01% 1105
2025
Q1 		$2.65M Sell
76,699
-1,252
-2% -$42.2K 0.01% 1141
2024
Q4 		$2.14M Buy
77,951
+5,143
+7% +$133K 0.01% 1262
2024
Q3 		$1.85M Sell
72,808
-6,482
-8% -$170K ﹤0.01% 1337
2024
Q2 		$2.01M Sell
79,290
-4,485
-5% -$123K 0.01% 1288
2024
Q1 		$2.59M Sell
83,775
-1,762
-2% -$59.9K 0.01% 1167
2023
Q4 		$3.45M Sell
85,537
-12,062
-12% -$362K 0.01% 1104
2023
Q3 		$2.57M Sell
97,599
-5,747
-6% -$163K 0.01% 1177
2023
Q2 		$1.78M Buy
103,346
+41,287
+67% +$621K 0.01% 1329
2023
Q1 		$1.03M Sell
62,059
-75,063
-55% -$875K ﹤0.01% 1469
2022
Q4 		$1.04M Sell
137,122
-4,102
-3% -$39.3K ﹤0.01% 1478
2022
Q3 		$1.4M Sell
141,224
-24,199
-15% -$251K ﹤0.01% 1433
2022
Q2 		$1.5M Sell
165,423
-32,666
-16% -$273K ﹤0.01% 1446
2022
Q1 		$2.01M Buy
198,089
+53,900
+37% +$553K ﹤0.01% 1495
2021
Q4 		$2.4M Buy
144,189
+5,000
+4% +$212K ﹤0.01% 1233
2021
Q3 		$6.52M Hold
139,189
– – 0.01% 942
2021
Q2 		$8.48M Buy
139,189
+12,500
+10% +$714K 0.02% 844
2021
Q1 		$7.8M Buy
126,689
+22,789
+22% +$1.49M 0.02% 861
2020
Q4 		$7.39M Sell
103,900
-12,900
-11% -$622K 0.02% 829
2020
Q3 		$4.38M Hold
116,800
– – 0.01% 977
2020
Q2 		$3.81M Buy
116,800
+1,100
+1% +$33.5K 0.01% 965
2020
Q1 		$3.35M Buy
115,700
+81,400
+237% +$2.52M 0.01% 919
2019
Q4 		$1.2M Hold
34,300
– – ﹤0.01% 1202
2019
Q3 		$736K Buy
+34,300
New +$949K ﹤0.01% 1211

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

State of Wisconsin Investment Board's BBIO Position: Q2 2026 in Review

State of Wisconsin Investment Board reduced its BridgeBio Pharma (BBIO) stake by 2.1% in Q2 2026, selling an estimated $133K and leaving 88,181 shares worth $6.57M. The position accounts for 0.01% of the portfolio, ranked #906.

State of Wisconsin Investment Board first reported a position in BBIO in Q3 2019 and has held it in 28 quarters since. The position peaked at $8.48M in Q2 2021. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • State of Wisconsin Investment Board held 88,181 shares of BridgeBio Pharma worth $6.57M as of Q2 2026.
  • State of Wisconsin Investment Board sold 1,895 BridgeBio Pharma shares in Q2 2026, an estimated $133K.
  • BridgeBio Pharma made up 0.01% of State of Wisconsin Investment Board's portfolio in Q2 2026, its #906 holding.
  • State of Wisconsin Investment Board first reported a position in BridgeBio Pharma in Q3 2019 and has held it in 28 quarters since.
  • State of Wisconsin Investment Board's BridgeBio Pharma position peaked at $8.48M in Q2 2021.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.